JPRN-UMIN000039221已完成未知
Comparison of the efficacy of insulin degludec/insulin aspart and insulin degludec/liraglutide in patients with type 2 diabetes - Comparison of the efficacy of insulin degludec/insulin aspart and insulin degludec/liraglutide in patients with type 2 diabetes
Minami Osaka Hospital0 个研究点目标入组 24 人开始时间: 2020年2月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with a history of severe ketosis, diabetic coma or previous coma within 6 weeks of this study. 2.Patients with a history of severe hypoglycemia (diabetic coma or pre-coma and convulsions needing third person assistance) within 6 weeks of this study. 3.Patients with severe renal dysfunction (eGFR less than 30mL/min/1.73m2 or serum creatinine 2.0mg/dL and more) or end-stage renal failure on dialysis. 4.Patients with proliferative retinopathy (however, patients who have undergone photocoagulation and have stable symptoms can be included). 5.Patients with a history of surgery for severe gastrointestinal disease. 6.Pregnant or possibly pregnant and lactating patients. 7.Patients with severe infections, before and after surgery, with severe trauma. 8.Patients receiving systemic corticosteroids. 9.Patients with severe liver dysfunction (high AST or ALT 100 U/L and more). 10.Patients with a history of allergy to the drug to be used in this study. 11.Patients with malignancy or a history of malignancy. 12.Patients judged by the investigator to be inappropriate as subjects.
研究者
相似试验
已完成
4 期
The efficacy of insulin degludec/insulin aspart switching from insulin glargine or degludec about glycemic metabolism in type 2 diabetes patientsType 2 diabetesJPRN-UMIN000025199Hokkaido University Hospital60
招募中
Unknown
Comparison of insulin degludec/liraglutide versus insulin degludec in multiple daily injection therapy on subjects with type 2 diabetes; time to reach target glycemic levelsType 2 diabetesJPRN-UMIN000052156Kushiro Red Cross Hospital30
进行中（未招募）
不适用
The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensificatioMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersDiabetes Mellitus, Type 2EUCTR2011-004665-32-GBovo Nordisk A/S320
进行中（未招募）
不适用
The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensification.Diabetes Mellitus Type 2MedDRA version: 15.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-004665-32-ITOVO NORDISK320
进行中（未招募）
不适用
The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensificatioDiabetes Mellitus, Type 2EUCTR2011-004665-32-DEovo Nordisk A/S320